Get the Stockscreener App
0.164
6.12%
-0.0107
After Hours:
.16
-0.004
-2.44%
Genprex Inc stock is traded at $0.164, with a volume of 2.61M.
It is down -6.12% in the last 24 hours and down -35.00% over the past month.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.
See More
Previous Close:
$0.1747
Open:
$0.1799
24h Volume:
2.61M
Relative Volume:
0.69
Market Cap:
$5.49M
Revenue:
-
Net Income/Loss:
$-22.71M
P/E Ratio:
-0.014
EPS:
-11.71
Net Cash Flow:
$-18.24M
1W Performance:
-2.55%
1M Performance:
-35.00%
6M Performance:
-56.27%
1Y Performance:
-75.58%
1-Day Range:
$0.1489
$0.1799
1-Week Range:
$0.1489
$0.1848
52-Week Range:
$0.14
$3.97
Genprex Inc Stock (GNPX) Company Profile
Name
Genprex Inc
Sector
Industry
Phone
512-537-7997
Address
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
Compare GNPX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GNPX
Genprex Inc
|
0.164 | 5.85M | 0 | -22.71M | -18.24M | -11.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Genprex Inc Stock (GNPX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-21 | Initiated | National Securities | Buy |
| Apr-29-19 | Initiated | Noble Capital Markets | Outperform |
Genprex Inc Stock (GNPX) Latest News
Strategies to average down on Genprex Inc2025 Investor Takeaways & Smart Money Movement Tracker - Newser
Smart tools for monitoring Genprex Inc.’s price action2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - Newser
Leading vs lagging indicators on Genprex Inc. performance2025 Price Momentum & Risk Controlled Stock Alerts - Newser
Real time breakdown of Genprex Inc. stock performanceQuarterly Trade Summary & Weekly Sector Rotation Insights - Newser
Genprex Inc. stock chart pattern explained2025 EndofYear Setup & Daily Growth Stock Investment Tips - Newser
Strategies to average down on Genprex Inc.2025 Earnings Surprises & Safe Entry Point Alerts - Newser
Using RSI to spot recovery in Genprex Inc.2025 Short Interest & Safe Swing Trade Setup Alerts - Newser
Trend analysis for Genprex Inc. this weekBuy Signal & Technical Pattern Based Signals - Newser
Can volume confirm reversal in Genprex Inc.Earnings Summary Report & Verified High Yield Trade Plans - Newser
Genprex Inc. stock daily chart insightsJuly 2025 Closing Moves & Free Safe Entry Trade Signal Reports - Newser
Published on: 2025-08-30 13:21:40 - Newser
Short interest data insights for Genprex Inc.July 2025 Intraday Action & Community Consensus Stock Picks - Newser
Earnings visualization tools for Genprex Inc.Weekly Stock Summary & High Conviction Buy Zone Picks - Newser
Multi factor analysis applied to Genprex Inc.Market Rally & Free Safe Capital Growth Stock Tips - Newser
Will Volume Confirm Reversal in Genprex Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Genprex Inc. Building a Base Near Support getLinesFromResByArray error: size == 0 - thegnnews.com
Using fundamentals and technicals on Genprex Inc.Profit Target & Fast Gain Swing Trade Alerts - Newser
Genprex Inc. stock trend outlook and recovery pathWall Street Watch & Verified Momentum Stock Ideas - Newser
Visual trend scoring systems applied to Genprex Inc.Weekly Profit Report & Weekly Consistent Profit Watchlists - Newser
What dividend growth rate does Genprex Inc. offerWeekly Trend Report & Fast Momentum Entry Tips - sundaytimes.kr
Short interest data insights for Genprex Inc2025 Dividend Review & Stepwise Trade Execution Plans - Newser
Genprex Inc Stock (GNPX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):